As of the latest SEC filings, Intellia Therapeutics, Inc. (NTLA) is held by 208 institutional funds. The largest fund shareholder is ARK Innovation ETF (ARKK), holding an estimated $133,486,252.68 in market value, representing 2.06% of its portfolio.
Funds holding Intellia Therapeutics, Inc. (NTLA)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- NTLA
- CIK:
- 0001652130
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ARKK
ARK Innovation ETF
|
ETF | Independent / Boutique | 2.06% | $133,486,252.68 | 9,902,541 | Apr 30, 2026 | Jun 23, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.65% | $48,117,729.06 | 3,753,333 | Mar 31, 2026 | May 28, 2026 |
|
ARKG
ARK Genomic Revolution ETF
|
ETF | Independent / Boutique | 3.82% | $47,158,418.52 | 3,498,399 | Apr 30, 2026 | Jun 23, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $47,003,978.74 | 3,666,457 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.02% | $34,911,872.70 | 2,723,235 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.05% | $34,754,302.08 | 2,710,944 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.41% | $22,155,938.74 | 1,607,833 | Feb 28, 2026 | Apr 24, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.05% | $19,522,565.22 | 1,522,821 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $16,555,183.92 | 1,291,356 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.05% | $14,807,806.96 | 1,098,502 | Apr 30, 2026 | Jun 26, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.10% | $12,208,537.28 | 952,304 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.13% | $10,709,020.34 | 835,337 | Mar 31, 2026 | May 28, 2026 |
|
VSEQX
VANGUARD STRATEGIC EQUITY FUND
|
MF | Vanguard | 0.09% | $9,288,487.42 | 724,531 | Mar 31, 2026 | May 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.04% | $7,797,123.62 | 565,829 | Feb 28, 2026 | Apr 24, 2026 |
|
-
ARK Venture Fund
|
CEF | Independent / Boutique | 0.89% | $7,659,187.72 | 568,189 | Apr 30, 2026 | Jun 23, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $7,417,622.42 | 538,289 | Feb 28, 2026 | Apr 24, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.11% | $7,143,441.76 | 518,392 | Feb 27, 2026 | Apr 24, 2026 |
|
DFSTX
U.S. SMALL CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.04% | $7,114,973.16 | 527,817 | Apr 30, 2026 | Jun 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.05% | $7,024,906.20 | 509,790 | Feb 28, 2026 | Apr 28, 2026 |
|
QASCX
Federated Hermes MDT Small Cap Core Fund
|
MF | Federated Hermes | 0.35% | $6,667,747.20 | 494,640 | Apr 30, 2026 | Jun 23, 2026 |
|
BDSKX
BlackRock Advantage Small Cap Core Fund
|
MF | BlackRock / iShares | 0.12% | $5,603,196.04 | 406,618 | Feb 27, 2026 | Apr 24, 2026 |
|
FPHAX
Select Pharmaceuticals Portfolio
|
MF | Fidelity | 0.35% | $5,298,410.00 | 384,500 | Feb 28, 2026 | Apr 24, 2026 |
|
DFAS
Dimensional U.S. Small Cap ETF
|
ETF | Dimensional Fund Advisors | 0.04% | $5,191,592.84 | 385,133 | Apr 30, 2026 | Jun 29, 2026 |
|
DFSCX
U.S. MICRO CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.07% | $5,080,261.52 | 376,874 | Apr 30, 2026 | Jun 24, 2026 |
|
PRFZ
Invesco RAFI US 1500 Small-Mid ETF
|
ETF | Invesco | 0.17% | $5,018,590.52 | 372,299 | Apr 30, 2026 | Jun 26, 2026 |
Advertisement (320x50)